|
Market Cap (26-May) $15,719,809 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (17-Apr) 8,415 (0.00%) (600th) |
|
52w High $0.064 |
52w Low $0.021 |
P/E - |
EPS 0 |
EMD released this announcement to the ASX on 7 April 2021, 9:22. The announcement is not marked as price sensitive, and is 24 page(s) in length and 4.8MB in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Emyria Drug Registration Model - EMD-003 snapshot | 7 April 2021, 9:22 |
| CAN: Cann and Emyria investor webinar | 30 March 2021, 15:32 |
| Emyria and Cann Group Investor Webinar | 30 March 2021, 15:24 |
| Emyria and Cann Partner to Register CBD Product | 29 March 2021, 9:22 |
You must be logged in to post a reply.
Emyria 